Rheumatoid arthritis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• JAK 9
• TNF 9
• STAT3 0
• IL-6 2
• PI3K 0
• NLRP3 0
• CD19 17
• MAPK 0
• HIF-1 0
• NRF2 0
• mTOR 0
• AKT 0
• IL-17 0
• STING 0
• RANKL 0
• PPAR 0
• COX-2 0
• IL-1 0
• TLR4 0
• CD20 2
• TP53 0
• ERK 0
• PD-1 1
• SIRT1 0
• BCMA 7
• GLP-1 0
• MMP-9 0
• CTLA-4 1
• CTNNB1 0
• GPX4 0
• JNK 0
• SGLT2 1
• VEGF 1
• CD40 0
• HMGB1 0
• AMPK 0
• APOE 0
• AQP4 0
• CCR5 0
• FGFR 0
• IL-15 1
• METTL3 0
• PKM2 0
• TYK2 0
• CD38 1
• CGRP 0
• CXCR4 0
• IDO1 0
• PD-L1 0
• TIGIT 0
• BTK 0
• CD47 0
• EGFR 0
• HDAC 0
• IDH 0
• IL-23 0
• IL-4 0
• KEAP1 0
• MEK 0
• MYC 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor

  NCT04530305· University Hospital, Montpellier· Updated 26 Oct 2026

  “Evolution of treatment sequencing for JAK inhibitors”Registry text, quoted unchanged. Source

• Withdrawn

  Cannabichromene Safety in Rheumatoid Arthritis

  NCT07087938· Crystal Lederhos Smith· Updated 23 Sept 2026

  “Study did not begin recruiting participants due to insufficient preclinical evidence resulting in FDA clinical hold.”Registry text, quoted unchanged. Source

• Suspended

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Updated 21 Sept 2026

  “Administrative”Registry text, quoted unchanged. Source

• Terminated

  CD40L Antagonism in Rheumatoid Arthritis (RA)

  NCT05306353· National Institute of Allergy and Infectious Diseases (NIAID)· Updated 20 Jul 2026

  “The study is being closed early due to insufficient participant enrollment across study sites.”Registry text, quoted unchanged. Source

• Withdrawn

  An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)

  NCT07706868· Swedish Orphan Biovitrum· Updated 16 Jul 2026

  “Business decision”Registry text, quoted unchanged. Source

• Withdrawn

  Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis

  NCT02720874· Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center· Updated 2 Jul 2026

  “Terminated due to several programmatic delays such as personnel transitions and departures, challenges to replace them as specified in the protocol, and delays due to COVID-19 pandemic-related institutional closures and clinical research pauses.”Registry text, quoted unchanged. Source

• Terminated

  A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

  NCT06859294· Eli Lilly and Company· Updated 17 Jun 2026

  “The interim analysis data failed to demonstrate the intended treatment effect.”Registry text, quoted unchanged. Source

• Withdrawn

  An Open-label Study of GC012F in Rheumatoid Arthritis.

  NCT07315503· Institute of Hematology & Blood Diseases Hospital, China· Updated 10 Jun 2026

  “Due to the sponsor's adjustment of the research and development strategy for this clinical trial, this study was prematurely terminated, and no subjects were recruited for this study”Registry text, quoted unchanged. Source

• Terminated

  COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

  NCT05000216· National Institute of Allergy and Infectious Diseases (NIAID)· Updated 10 Jun 2026

  “The study was closed due to continued enrollment hurdles.”Registry text, quoted unchanged. Source

• Terminated

  TESS V3 Modular Total Shoulder System PMCF

  NCT05002959· Zimmer Biomet· Updated 9 Jun 2026

  “Termination of PMCF study due to product discontinuation (commercial reasons)”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body

  NCT07649265· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis

  NCT07916623· Ege University· Source

• A Study of AZD0120 in Autoimmune Diseases

  NCT07295847· AstraZeneca· Source

• A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

  NCT07363590· Merck Sharp & Dohme LLC· Source

• Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis

  NCT07904754· AbbVie· Source

• Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

  NCT07201558· AstraZeneca· Source

• A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)

  NCT07895524· Merck Sharp & Dohme LLC· Source

• COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

  NCT06599658· McGill University Health Centre/Research Institute of the McGill University Health Centre· Source

• Efficacy of JAK STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis

  NCT05788705· Adel A.Gomaa· Source

• A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

  NCT07412704· Bristol-Myers Squibb· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 43
• Organoids 3
• Mendelian Randomization Analysis 96
• CRISPR-Cas Systems 1
• Gene Expression Profiling 121
• Sequence Analysis, RNA 17
• Exome Sequencing 2
• Proteomics 52
• Metabolomics 44
• Mass Spectrometry 7
• Flow Cytometry 33
• Immunohistochemistry 18
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 5
• Magnetic Resonance Imaging 58
• Machine Learning 87
• Deep Learning 9
• Cohort Studies 160
• Genome-Wide Association Study 113

• Integrative analysis reveals shared biomarkers and pathways in osteoporosis and rheumatoid arthritis using machine learning and single-cell sequencing.

  PLoS One, Nov 2026

• Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis: A real-world disproportionality and machine learning analysis.

  Medicine (Baltimore), Oct 2026

• Predicting cholesterol screening behavior using machine learning: Social-ecological approach.

  Health Informatics J, Oct 2026

• [Explore the potential diagnostic markers of primary Sjögren syndrome by bioinformatics combined with machine learning].

  Beijing Da Xue Xue Bao Yi Xue Ban, Oct 2026

• AI-Guided Histopathological and Molecular Phenotyping of Salivary Glands in Sjögren's Disease: Subtyping, Mechanistic Insights, and Translational Implications-A Systematic Review and Structured Functional Synthesis.

  Med Sci (Basel), Oct 2026

• Interpretable machine learning models for predicting tocilizumab response in rheumatoid arthritis using clinical data.

  BMC Med Inform Decis Mak, Sept 2026

• Lysosome-targeted fluorescent probe for real-time imaging of hypochlorite in rheumatoid arthritis and machine learning-assisted quantification in plant tissues.

  Anal Chim Acta, Sept 2026

• Shared pathogenic genes and therapeutic targets in periodontitis and systemic juvenile idiopathic arthritis: An integrative bioinformatics and machine learning study.

  PLoS Comput Biol, Sept 2026

• Machine learning identifies plasma-derived exosomal miRNAs associated with low muscle mass in Tibetan patients with rheumatoid arthritis.

  Sci Rep, Sept 2026

• Osteoporosis prediction in primary Sjögren's syndrome: development and external validation of a machine-learning comparison model.

  Rheumatology (Oxford), Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.